pmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site

Formats:

Infect Immun. 1997 May; 65(5): 1926–1930.
PMCID: PMC175242
Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.
R W Titball, A M Howells, P C Oyston, and E D Williamson
Defence Evaluation and Research Agency, Salisbury, Wiltshire, United Kingdom.
Abstract
The caf operon from Yersinia pestis encoding the structural subunit (caf1), the molecular chaperone (caf1M), the outer membrane anchor (caf1A), and the regulatory protein (caf1R) was cloned into Salmonella typhimurium SL3261 aroA. The recombinant Salmonella organisms were encapsulated when cultured at 37 degrees C but not when cultured at 28 degrees C. Oral inoculation of mice with the recombinant Salmonella induced predominantly an immunoglobulin G2a response to F1 antigen, and isolated T cells showed a recall response to soluble or Salmonella-associated F1 antigen. Mice immunized with S. typhimurium SL3261 aroA expressing F1 antigen intracellularly developed lower antibody responses to F1 antigen and showed a T-cell recall response only to Salmonella-associated F1 antigen. Mice immunized orally with two doses of the recombinant Salmonella which expressed F1 antigen on the surface were protected against 10(7) 50% lethal doses (LD50) of virulent Y. pestis given by the subcutaneous route of challenge, whereas mice immunized with the recombinant Salmonella expressing F1 antigen intracellularly were only partially protected against 10(5) LD50 of Y. pestis.
Full Text
The Full Text of this article is available as a PDF (288K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Andrews GP, Heath DG, Anderson GW, Jr, Welkos SL, Friedlander AM. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun. 1996 Jun;64(6):2180–2187. [PubMed]
  • Brett SJ, Dunlop L, Liew FY, Tite JP. Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology. 1993 Oct;80(2):306–312. [PubMed]
  • BURROWS TW, BACON GA. The basis of virulence in Pasteurella pestis: the development of resistance to phagocytosis in vitro. Br J Exp Pathol. 1956 Jun;37(3):286–299. [PubMed]
  • Cárdenas L, Clements JD. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin Microbiol Rev. 1992 Jul;5(3):328–342. [PubMed]
  • Charles I, Dougan G. Gene expression and the development of live enteric vaccines. Trends Biotechnol. 1990 May;8(5):117–121. [PubMed]
  • Cowling P, Moss P. Infectivity of pneumonic plague. BMJ. 1994 Nov 19;309(6965):1369. [PubMed]
  • FOX EN, HIGUCHI K. Synthesis of the fraction I antigenic protein by Pasteurella pestis. J Bacteriol. 1958 Feb;75(2):209–216. [PubMed]
  • Fulop M, Manchee R, Titball R. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine. 1995 Sep;13(13):1220–1225. [PubMed]
  • Galyov EE, Smirnov OYu, Karlishev AV, Volkovoy KI, Denesyuk AI, Nazimov IV, Rubtsov KS, Abramov VM, Dalvadyanz SM, Zav'yalov VP. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes. FEBS Lett. 1990 Dec 17;277(1-2):230–232. [PubMed]
  • Galyov EE, Karlishev AV, Chernovskaya TV, Dolgikh DA, Smirnov OYu, Volkovoy KI, Abramov VM, Zav'yalov VP. Expression of the envelope antigen F1 of Yersinia pestis is mediated by the product of caf1M gene having homology with the chaperone protein PapD of Escherichia coli. FEBS Lett. 1991 Jul 29;286(1-2):79–82. [PubMed]
  • Gupta RK, Siber GR. Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay. J Immunol Methods. 1995 Apr 12;181(1):75–81. [PubMed]
  • Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SH. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1458–1463. [PubMed]
  • Karlyshev AV, Galyov EE, Abramov VM, Zav'yalov VP. Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett. 1992 Jun 22;305(1):37–40. [PubMed]
  • Karlyshev AV, Galyov EE, Smirnov OYu, Guzayev AP, Abramov VM, Zav'yalov VP. A new gene of the f1 operon of Y. pestis involved in the capsule biogenesis. FEBS Lett. 1992 Feb 3;297(1-2):77–80. [PubMed]
  • Marshall JD, Jr, Bartelloni PJ, Cavanaugh DC, Kadull PJ, Meyer KF. Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine. J Infect Dis. 1974 May;129(Suppl):S19–S25. [PubMed]
  • Meyer KF. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ. 1970;42(5):653–666. [PubMed]
  • Meyer KF, Hightower JA, McCrumb FR. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. J Infect Dis. 1974 May;129(Suppl):S41–S45. [PubMed]
  • Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. [PubMed]
  • Oyston PC, Williamson ED, Leary SE, Eley SM, Griffin KF, Titball RW. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun. 1995 Feb;63(2):563–568. [PubMed]
  • Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine. 1995 Nov;13(16):1551–1556. [PubMed]
  • Simpson WJ, Thomas RE, Schwan TG. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg. 1990 Oct;43(4):389–396. [PubMed]
  • Sjöstedt A, Sandström G, Tärnvik A. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Res Microbiol. 1990 Sep–Oct;141(7-8):887–891. [PubMed]
  • Snapper CM, Finkelman FD, Paul WE. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med. 1988 Jan 1;167(1):183–196. [PubMed]
  • Stoker NG, Fairweather NF, Spratt BG. Versatile low-copy-number plasmid vectors for cloning in Escherichia coli. Gene. 1982 Jun;18(3):335–341. [PubMed]
  • Thatte J, Rath S, Bal V. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response. Int Immunol. 1993 Nov;5(11):1431–1436. [PubMed]
  • Williams JE, Arntzen L, Tyndal GL, Isaäcson M. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982. Bull World Health Organ. 1986;64(5):745–752. [PubMed]
  • Williams RC, Jr, Gewurz H, Quie PG. Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J Infect Dis. 1972 Sep;126(3):235–241. [PubMed]
  • Williamson ED, Eley SM, Griffin KF, Green M, Russell P, Leary SE, Oyston PC, Easterbrook T, Reddin KM, Robinson A, et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol. 1995 Dec;12(3-4):223–230. [PubMed]